Inogen to Share Third Quarter 2024 Financial Results
Inogen, Inc. (NASDAQ: INGN), based in Goleta, California, is preparing to release its financial results for the third quarter of 2024. This exciting announcement will be made after the market closes on a Thursday in November. Following the results, Inogen will conduct a conference call to discuss these findings and answer any questions from participants.
Details of the Financial Call
The conference call is scheduled for 2:00 PM PT (5:00 PM ET) on the same day as the financial results are announced. Interested individuals can join the call by dialing the provided numbers. For those calling from within the United States, the number is (877) 841-3961. For international callers, the number is (201) 689-8589. It's important for callers to mention Inogen when joining the call.
Accessing the Webcast and Replay
For those unable to participate in the live call, Inogen will provide a live audio webcast of the conference call, which interested parties can access through the official Investor Relations website. This broadcast will also be archived, allowing for convenient access over the next six months. Furthermore, a replay of the conference call will be available approximately three hours after the live session ends, continuing until mid-November.
Inogen's Commitment to Transparency
Inogen remains dedicated to transparency and regular communication with its investors. The company effectively utilizes its Investor Relations platform to ensure that critical, non-public information is disclosed in compliance with regulatory requirements.
About Inogen
Inogen, Inc. (NASDAQ: INGN) stands as a leader in the medical technology sector, particularly known for its innovative respiratory products designed for home healthcare. The company specializes in developing, manufacturing, and marketing portable oxygen concentrators that provide supplemental oxygen to patients with chronic respiratory issues. Inogen collaborates with patients, healthcare providers, and distributors to make its oxygen therapy products widely accessible, facilitating greater mobility for those managing respiratory illnesses.
Innovation and Patient Care
By continuously advancing its technologies, Inogen supports patients in maintaining their quality of life. Its commitment to innovation in the field of respiratory care sets it apart as a vital resource for individuals experiencing difficulty with oxygenation. As Inogen approaches its financial results announcement, stakeholders eagerly anticipate the impactful insights that may arise concerning the company’s progress and future direction.
Frequently Asked Questions
When will Inogen report its Q3 2024 financial results?
Inogen will report its third quarter financial results after market closure on November 7, 2024.
How can I join the Inogen financial results conference call?
To join the conference call, dial (877) 841-3961 for US callers and (201) 689-8589 for international callers, referencing Inogen.
Is there a way to listen to a recording of the conference call?
Yes, a replay of the call will be available about three hours after it ends, accessible until November 14, 2024.
Where can I find Inogen's Investor Relations information?
You can find Inogen's Investor Relations information on their official website, which includes updates and material information.
What type of products does Inogen manufacture?
Inogen manufactures portable oxygen concentrators for patients requiring supplemental long-term oxygen therapy due to chronic respiratory conditions.
